STRIDES PHARMA SCIENCE STOCK SEES SURGE OF 8.33% ON JANUARY 1, 2025, OUTPERFORMING SECTOR

KOLKATA, INDIA - January 1, 2025 - Strides Pharma Science Ltd., a mid-cap player in the pharmaceuticals and drugs industry, saw its stock rise by 8.33% on January 1, 2025, outperforming the sector by 7.27%. The company's stock reached an intraday high of Rs 709.8, with a total return of 7.69% over two days.

According to market analysts, Strides Pharma Science has been on a positive trajectory for the last two days, accumulating a notable increase in its stock price. However, when examining moving averages, the company's stock is currently above its 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed short- to long-term trends.

In terms of broader performance, the stock's one-day performance stands at 9.16%, contrasting with the Sensex, which recorded a slight decline of 0.09%. Over the past month, Strides Pharma Science has faced challenges, showing a decline of 56.08%, while the Sensex has decreased by 2.18%.

The company is currently rated as a 'Hold' by MarketsMOJO and is part of their MomentumNow Stocks since April 3, 2024.

"Strides Pharma Science's recent surge in stock price may be attributed to its strong fundamentals and positive trends," said Dr. Sami Sadeque, a market analyst at Alayaran.com. "However, investors should keep a close eye on the company's future performance and stay updated with the latest news and trends."